title: [Infectious-toxic model of plague in mice].
abstract: OBJECTIVE
  To develop infectious-toxic model of plague in mice and to assess perspectives of its use for selection of new vaccine preparations.
  
  
  METHODS
  Cells of virulent strains of Yersinia pestis 231 and 231 FI- incubated in lysates of human erythrocytes for their activation as well as suspensions of these strains in isotonic solution of NaCl were used for subcutaneous inoculation of infection-nanve and immune mice.
  
  
  RESULTS
  It was shown that activated cultures were characterized by maximal virulence (LD50 = 1-3 CFU) and caused rapid infection--mean length of survival reduced on 1 - 3 days (P < or = 0.01). Vaccine strain EV used by conventional way of inoculation (suspension in isotonic solution of NaCl) induced strong antibacterial immunity (index of immunity--10(5)), whereas activated (in lysate of erythrocytes) cells of Y. pestis 231 strain overcame it (index of immunity--10(2)). LD50 value of Y. pestis 231 FI- for immune and nanve animals was 3 m.c. (1 CFU), which demonstrates the absence of ability of EV strain to induce antitoxic immunity in the macroorganism.
  
  
  CONCLUSIONS
  Use of two models of infection allows to make more adequate prognosis of efficacy for relevant vaccine preparations.
authors.forename: I V
authors.initials: IV
authors.lastname: Ryzhko
authors.forename: B N
authors.initials: BN
authors.lastname: Mishan'kin
authors.forename: R I
authors.initials: RI
authors.lastname: Tsuraeva
authors.forename: A I
authors.initials: AI
authors.lastname: Shcherbaniuk
authors.forename: B I
authors.initials: BI
authors.lastname: Anisimov
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D007928:Lethal Dose 50; D051379:Mice; D010930:Plague / Q000276:immunology / Q000517:prevention & control*; D010931:Plague Vaccine / Q000008:administration & dosage / Q000276:immunology* / Q000302:isolation & purification; D014774:Virulence; D015010:Yersinia pestis / Q000276:immunology* / Q000472:pathogenicity
chemical_list: D010931:Plague Vaccine